Claudia Stefanutti is an expert in Cardiology at Sapienza University of Rome (Italy). As of October 2026, ScienceLeadR ranks Claudia Stefanutti in the top 1% of experts worldwide for Hyperlipidemias, Dyslipidemias and Lipid Metabolism Disorders. Claudia Stefanutti has authored 153 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 491 (community average: 125). How the SLR is computed.

LeadR Profile

Claudia Stefanutti Sapienza University of Rome Italy
491 ScienceLeadR Reputation 491
Network Map

Cardiology

Subspecialties: Genetics - Hematology - Nutrition

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Claudia Stefanutti, MD received her Ph.D. in Experimental Medicine (Atherosclerosis) from University of Siena, Italy, in 1988. Her specialties are: Liver and Metabolic Diseases (1986) and Emergency Surgery (1994), both received from University ‘Sapienza’ of Rome. She introduced innovative extracorporeal therapeutic techniques at the Department of Hematology from 1987. During her training in surgery she introduced for the first time, the autologous blood recovery from wound or surgical site. University graduation 1982 Sapienza University of Rome Medicine and Surgery 110/110 cum Laude Post-graduate studies 1987-1989 Sapienza University of Rome - CNR National Competition 1987 Italian National Research Council (Boll. Uff. CNR n. 6 del 22/10/86) Data banks for molecular biology. Human Genome. Elegible Licensure 01 1986 Ordine provinciale di Roma dei Medici Chirurghi e degli Odontoiatri M37342. Academic Appointments: Start End Institution Position 1991-2001 Sapienza University of Rome Graduate Technician (VII) Umberto I Hospital 2001; Sapienza University of Rome Researcher (RTI) 2016-2026 National Scientific Qualification ASN, Associate Professor 2019-2029 National Scientific Qualification ASN Full Professor. Other Appointments Start End Institution Position 2017-2017 University of Niš, Serbia, Visiting Professor. 2018-2019 Medical University of Vienna, Austria, Visiting Professor 2019. http://www.expertscape.com/ex/hyperlipidemias Recognized as Expertscape World Expert in Hyperlipidemias (2019). 2017 Publons Top Reviewer for 2017-2018. 2018 Elsevier Reviewer Acknowledgement. Top 2% scientists, Leading Minds in Science for the years 2022-2024. Stanford University's Top 2% Scientists list. Spoken Languages: English, Turkish, French (Basic), Japanese (Elementary), learned on site. 152+ publications, including 58 as first author, 14 as last author and 3 clinical studies (only on web). Total publications March 2026: 354. top 1% of experts worldwide in Hyperlipidemias (out of 12 241). 2025 ÖSTERREICHISCHES AKADEMISCHES INSTITUT FÜR ERNÄHRUNGSMEDIZIN LOCATION: Vienna, Austria. Award for scientific and research activity in Europe.

Organizations

Career arc: 1988 - 2026

Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 153

Citations

Citations: 4 442 1st author: 62 Last author: 16 Unique author: 8


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Efficacy of plasma exchange and exchange transfusion in the clinical management of severe hypertriglyceridemia in emergency.
PMID 42756739 — emergencies, hypertriglyceridemia, signs and symptoms, pancreatitis, plasma exchange, therapeutics, plasma
Mol Genet Metab Rep20260
Lipoprotein apheresis in the era of new lipid-lowering therapies.
PMID 42155048 — cholesterol, vldl, lipoproteins, blood component removal, cardiology, cholesterol, therapeutics, lipoprotein(a)
Eur Heart J Top journal20261
Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study.
PMID 41671678 — genes, receptors, ldl, receptors, lipoprotein, lipoproteins, arteriosclerosis, genotype, therapeutics, lipoproteins, ldl
Atherosclerosis20260
Obituary: Professor Gilbert R. Thompson FRCP Emeritus Professor of clinical lipidology, imperial college London.
PMID 41650566 — arteriosclerosis
Atherosclerosis20260
Safety and effectiveness of evinacumab in an infant with homozygous familial hypercholesterolemia: A new renaissance for the very young?
PMID 40187919 — hyperlipoproteinemia type ii, safety, lipoproteins, cholesterol, therapeutics, mutation, infant, hypercholesterolemia, homozygous familial hypercholesterolemia
J Clin Lipidol20250

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 3

By status:

Completed 3

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

LeadR Networks

Main global connection map